# Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2)

> **NCT04337190** · — · UNKNOWN · sponsor: **University Hospital, Angers** · enrollment: 100 (estimated)

## Conditions studied

- COVID
- Acute Respiratory Distress Syndrome

## Interventions

- **BIOLOGICAL:** blood sampling

## Key facts

- **NCT ID:** NCT04337190
- **Lead sponsor:** University Hospital, Angers
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-03
- **Primary completion:** 2020-10-06
- **Final completion:** 2020-12-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04337190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04337190, "Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04337190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*